Status: Not yet recruiting
Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing Treatment
This is a randomized, open-label, positive-controlled, multicenter Phase Ш study to evaluate the efficacy and safety of mitoxantrone hydrochloride liposome injection combined with capecitabine versus capecitabine monotherapy in patients with recurrent metastatic nasopharyngeal carcinoma.
Participants needed: 500
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.Updated: Feb 8, 2023
Eligibility criteria
Willing to participate in the study and sign the informed consent form (ICF). [+9]
Severe allergy to mitoxantrone or liposome; Previous severe, unexpected reaction... [+15]